Parkwood LLC Cytek Biosciences, Inc. Transaction History

Parkwood LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.69 - $11.99 $115,951 - $207,810	17,332 Added 56.07%	48,244 $412,000
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $75,892 - $121,122	-8,992 Reduced 22.53%	30,912 $284,000
Q4 2022 Feb 14, 2023	SELL	$9.71 - $15.86 $23,614 - $38,571	-2,432 Reduced 5.74%	39,904 $407,000
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $482 - $679	44 Added 0.1%	42,336 $623,000
Q2 2022 Aug 15, 2022	BUY	$7.41 - $11.56 $96,189 - $150,060	12,981 Added 44.29%	42,292 $42,000
Q1 2022 May 13, 2022	SELL	$9.89 - $17.25 $29,828 - $52,026	-3,016 Reduced 9.33%	29,311 $316,000
Q4 2021 Feb 11, 2022	BUY	$16.14 - $25.04 $521,757 - $809,468	32,327 New	32,327 $528,000

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $874M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.